trending Market Intelligence /marketintelligence/en/news-insights/trending/6aajoijwzzm-rgafbesrbg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Verastem Oncology plans to raise $43M through common stock offering

Blog

JMP Securities is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

M&A rebound sparks optimism for near-term deal activity

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition


Verastem Oncology plans to raise $43M through common stock offering

Verastem Inc. plans to raise about $43.0 million through an offering of 7,166,666 of its common shares at $6.00 apiece.

The shares were offered to funds managed by healthcare-focused private equity firm Consonance Capital Partners LP.

The offering is expected to close June 18, subject to customary closing conditions.

Needham, Mass.-based Verastem is a biopharmaceutical company which focuses on discovering and developing cancer drugs.